Jeremiah E Moore - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jeremiah E Moore

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Leukemia Research|February 14, 2021

Targeted therapy for treatment of patients with classical hairy cell leukemiaJeremiah E Moore, Kendra Delibert, Andrea M Baran, et al.

Journal of the American Heart Association|March 9, 2023

Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative DisordersSaadia Sherazi, Susan Schleede, Scott McNitt, et al.

Leukemia Research|April 1, 2023

Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactionsJeremiah E Moore, Paige C Bloom, Charles C Chu, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Leukemia Research|February 14, 2021

Targeted therapy for treatment of patients with classical hairy cell leukemiaJeremiah E Moore, Kendra Delibert, Andrea M Baran, et al.

Journal of the American Heart Association|March 9, 2023

Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative DisordersSaadia Sherazi, Susan Schleede, Scott McNitt, et al.

Leukemia Research|April 1, 2023

Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactionsJeremiah E Moore, Paige C Bloom, Charles C Chu, et al.

Pageof 1